How Do mRNA Vaccines Work?
By Morgan McSweeney
-
Feb 6, 2021 at 6:15AM
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Pfizer and Moderna both received FDA authorization for mRNA vaccines, and phase 3 data efficacy was sky high.
Related Articles
Why Novavax Was Tumbling by 12% This Week
Why Co-Diagnostics Trounced the Market on Thursday
Why Insulet Stock Is Soaring This Week
Why Liquidia Stock Rose as Much as 22% Higher Today
Medtronic (MDT) Q4 2022 Earnings Call Transcript
Motley Fool Returns
Market-beating stocks from our award-winning service.
Stock Advisor Returns
332%
332%
S&P 500 Returns
118%
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Cumulative Growth of a $10,000 Investment in Stock Advisor
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Our Most Popular Articles
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.